Please enable JavaScript to continue using this application.

Compare $DWTX vs $HOWL | Chartloom

Compare

$DWTX vs $HOWL

Dogwood Therapeutics Inc · Werewolf Therapeutics Inc

DWTX

Dogwood Therapeutics Inc

HOWL

Werewolf Therapeutics Inc

Compare $DWTX vs $HOWL

Comparing Dogwood Therapeutics Inc and Werewolf Therapeutics Inc

DWTXDogwood Therapeutics Inc

HOWLWerewolf Therapeutics Inc

DWTXDogwood Therapeutics Inc

Market cap

$47M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-67.0%

52W performance

-78.1%

FCF yield

-32.1%

HOWLWerewolf Therapeutics Inc

Market cap

$48M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

51.9%

52W performance

-47.9%

FCF yield

-63.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DWTX

HOWL

Detailed metrics comparison

DWTX

Dogwood Therapeutics Inc

HOWL

Werewolf Therapeutics Inc

Market Cap

DWTX$47M

HOWL$48M

Enterprise Value

DWTX$37M

HOWL$26M

Price

DWTX$1.40

HOWL$0.98

P/E Ratio

DWTXN/A

HOWLN/A

P/S Ratio

DWTX0.00x

HOWL2.27x

EV/Sales

DWTX0.00x

HOWL1.22x

EV/EBITDA

DWTX0.00x

HOWL0.00x

P/B Ratio

DWTX0.73x

HOWL2.77x

P/FCF Ratio

DWTXN/A

HOWLN/A

EV/FCF

DWTX-2.48x

HOWL-0.85x

PEG Ratio

DWTXN/A

HOWLN/A

Forward P/E (NTM)

DWTXN/A

HOWLN/A

Forward P/S (NTM)

DWTXN/A

HOWLN/A

Revenue (TTM)

DWTX$0

HOWL$21M

Revenue Growth (YoY)

DWTXN/A

HOWLN/A

Forward Rev Growth

DWTX613.9%

HOWL0.0%

Gross Margin (TTM)

DWTX0.0%

HOWL0.0%

Operating Margin (TTM)

DWTX0.0%

HOWL18.1%

EBITDA Margin (TTM)

DWTX0.0%

HOWL-104.4%

Net Margin (TTM)

DWTX0.0%

HOWL-164.8%

FCF Margin (TTM)

DWTXN/A

HOWL-143.6%

Net Income (TTM)

DWTX$-25M

HOWL$-35M

FCF (TTM)

DWTX$-15M

HOWL$-30M

EPS (TTM)

DWTX$0.00

HOWL-$0.71

ROE (TTM)

DWTX-3591.0%

HOWL-16698.0%

ROA (TTM)

DWTX-3028.0%

HOWL-5988.0%

ROIC (TTM)

DWTX-3591.0%

HOWL-8259.0%

Cash

DWTX$10M

HOWL$22M

Debt

DWTX$0

HOWL$0

Net Cash/Debt

DWTX$10M

HOWL$22M

Current Ratio (TTM)

DWTX3.89x

HOWL2.91x

Quick Ratio (TTM)

DWTX3.41x

HOWL2.80x

Debt/Equity (TTM)

DWTX0.00x

HOWL1.14x

Debt/Assets (TTM)

DWTX0.0%

HOWL0.0%

Interest Coverage (TTM)

DWTXN/A

HOWLN/A

Net Debt/EBITDA (TTM)

DWTX0.00x

HOWL0.00x

Beta

DWTX2.14

HOWL0.57

52W Performance

DWTX-78.1%

HOWL-47.9%

YTD Performance

DWTX-67.0%

HOWL51.9%

% from 52W High

DWTX-80.1%

HOWL-49.4%

% from 52W Low

DWTX9.4%

HOWL262.8%

Asset Turnover (TTM)

DWTX0.00x

HOWL0.87x

FCF Yield (TTM)

DWTX-32.1%

HOWL-63.3%

Earnings Yield (TTM)

DWTX-52.1%

HOWL-72.7%

Dividend Yield (TTM)

DWTXN/A

HOWLN/A

Rule of 40

DWTX0.0

HOWL-143.6

EV/GP/RG

DWTXN/A

HOWLN/A

Ticker research

View DWTX research View HOWL research

Metric	DWTX Dogwood Therapeutics Inc	HOWL Werewolf Therapeutics Inc
Market & Valuation
Market Cap	$47M	$48M
Enterprise Value	$37M	$26M
Price	$1.40	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	2.27x
EV/Sales	0.00x	1.22x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.73x	2.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.48x	-0.85x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$21M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	613.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	18.1%
EBITDA Margin (TTM)	0.0%	-104.4%
Net Margin (TTM)	0.0%	-164.8%
FCF Margin (TTM)	N/A	-143.6%
Net Income (TTM)	$-25M	$-35M
FCF (TTM)	$-15M	$-30M
EPS (TTM)	$0.00	-$0.71
ROE (TTM)	-3591.0%	-16698.0%
ROA (TTM)	-3028.0%	-5988.0%
ROIC (TTM)	-3591.0%	-8259.0%
Financial Health
Cash	$10M	$22M
Debt	$0	$0
Net Cash/Debt	$10M	$22M
Current Ratio (TTM)	3.89x	2.91x
Quick Ratio (TTM)	3.41x	2.80x
Debt/Equity (TTM)	0.00x	1.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.14	0.57
52W Performance	-78.1%	-47.9%
YTD Performance	-67.0%	51.9%
% from 52W High	-80.1%	-49.4%
% from 52W Low	9.4%	262.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.87x
FCF Yield (TTM)	-32.1%	-63.3%
Earnings Yield (TTM)	-52.1%	-72.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-143.6
EV/GP/RG	N/A	N/A
Ticker research	View DWTX research	View HOWL research

Valuation

P/S Ratio

DWTX

0.00x

HOWL

2.27x

EV/FCF

DWTX

-2.48x

HOWL

-0.85x

Growth & revenue

Forward Revenue Growth

DWTX

613.9%

HOWL

0.0%

Profitability & performance

Gross Margin

DWTX

0.0%

HOWL

0.0%

ROE

DWTX

-3591.0%

HOWL

-16698.0%

FCF Yield %

DWTX

-32.1%

HOWL

-63.3%

52-Week Performance

HOWL

-47.9%

DWTX

-78.1%

Detailed metrics comparison

DWTX

Dogwood Therapeutics Inc

HOWL

Werewolf Therapeutics Inc

Market Cap

DWTX$47M

HOWL$48M

Enterprise Value

DWTX$37M

HOWL$26M

Price

DWTX$1.40

HOWL$0.98

P/E Ratio

DWTXN/A

HOWLN/A

P/S Ratio

DWTX0.00x

HOWL2.27x

EV/Sales

DWTX0.00x

HOWL1.22x

EV/EBITDA

DWTX0.00x

HOWL0.00x

P/B Ratio

DWTX0.73x

HOWL2.77x

P/FCF Ratio

DWTXN/A

HOWLN/A

EV/FCF

DWTX-2.48x

HOWL-0.85x

PEG Ratio

DWTXN/A

HOWLN/A

Forward P/E (NTM)

DWTXN/A

HOWLN/A

Forward P/S (NTM)

DWTXN/A

HOWLN/A

Revenue (TTM)

DWTX$0

HOWL$21M

Revenue Growth (YoY)

DWTXN/A

HOWLN/A

Forward Rev Growth

DWTX613.9%

HOWL0.0%

Gross Margin (TTM)

DWTX0.0%

HOWL0.0%

Operating Margin (TTM)

DWTX0.0%

HOWL18.1%

EBITDA Margin (TTM)

DWTX0.0%

HOWL-104.4%

Net Margin (TTM)

DWTX0.0%

HOWL-164.8%

FCF Margin (TTM)

DWTXN/A

HOWL-143.6%

Net Income (TTM)

DWTX$-25M

HOWL$-35M

FCF (TTM)

DWTX$-15M

HOWL$-30M

EPS (TTM)

DWTX$0.00

HOWL-$0.71

ROE (TTM)

DWTX-3591.0%

HOWL-16698.0%

ROA (TTM)

DWTX-3028.0%

HOWL-5988.0%

ROIC (TTM)

DWTX-3591.0%

HOWL-8259.0%

Cash

DWTX$10M

HOWL$22M

Debt

DWTX$0

HOWL$0

Net Cash/Debt

DWTX$10M

HOWL$22M

Current Ratio (TTM)

DWTX3.89x

HOWL2.91x

Quick Ratio (TTM)

DWTX3.41x

HOWL2.80x

Debt/Equity (TTM)

DWTX0.00x

HOWL1.14x

Debt/Assets (TTM)

DWTX0.0%

HOWL0.0%

Interest Coverage (TTM)

DWTXN/A

HOWLN/A

Net Debt/EBITDA (TTM)

DWTX0.00x

HOWL0.00x

Beta

DWTX2.14

HOWL0.57

52W Performance

DWTX-78.1%

HOWL-47.9%

YTD Performance

DWTX-67.0%

HOWL51.9%

% from 52W High

DWTX-80.1%

HOWL-49.4%

% from 52W Low

DWTX9.4%

HOWL262.8%

Asset Turnover (TTM)

DWTX0.00x

HOWL0.87x

FCF Yield (TTM)

DWTX-32.1%

HOWL-63.3%

Earnings Yield (TTM)

DWTX-52.1%

HOWL-72.7%

Dividend Yield (TTM)

DWTXN/A

HOWLN/A

Rule of 40

DWTX0.0

HOWL-143.6

EV/GP/RG

DWTXN/A

HOWLN/A

Ticker research

View DWTX research View HOWL research

Metric	DWTX Dogwood Therapeutics Inc	HOWL Werewolf Therapeutics Inc
Market & Valuation
Market Cap	$47M	$48M
Enterprise Value	$37M	$26M
Price	$1.40	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	2.27x
EV/Sales	0.00x	1.22x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.73x	2.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.48x	-0.85x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$21M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	613.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	18.1%
EBITDA Margin (TTM)	0.0%	-104.4%
Net Margin (TTM)	0.0%	-164.8%
FCF Margin (TTM)	N/A	-143.6%
Net Income (TTM)	$-25M	$-35M
FCF (TTM)	$-15M	$-30M
EPS (TTM)	$0.00	-$0.71
ROE (TTM)	-3591.0%	-16698.0%
ROA (TTM)	-3028.0%	-5988.0%
ROIC (TTM)	-3591.0%	-8259.0%
Financial Health
Cash	$10M	$22M
Debt	$0	$0
Net Cash/Debt	$10M	$22M
Current Ratio (TTM)	3.89x	2.91x
Quick Ratio (TTM)	3.41x	2.80x
Debt/Equity (TTM)	0.00x	1.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.14	0.57
52W Performance	-78.1%	-47.9%
YTD Performance	-67.0%	51.9%
% from 52W High	-80.1%	-49.4%
% from 52W Low	9.4%	262.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.87x
FCF Yield (TTM)	-32.1%	-63.3%
Earnings Yield (TTM)	-52.1%	-72.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-143.6
EV/GP/RG	N/A	N/A
Ticker research	View DWTX research	View HOWL research